n,n-dimethylarginine has been researched along with Aortic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birand, A; Diker, M; Eksik, A; İyigün, T; Kaya, M; Örnek Diker, V; Satılmışoğlu, MH; Taşbulak, Ö | 1 |
| Arend, A; Aunapuu, M; Avolio, AP; Butlin, M; Eha, J; Kals, J; Kampus, P; Põdramägi, T; Salum, E; Zilmer, M | 1 |
2 other study(ies) available for n,n-dimethylarginine and Aortic Diseases
| Article | Year |
|---|---|
Increased plasma asymmetric dimethylarginine level is associated with ascending aorta dilatation: a case-control study.
Topics: Aged; Aorta; Aortic Diseases; Arginine; Case-Control Studies; Cross-Sectional Studies; Dilatation, Pathologic; Female; Humans; Male; Middle Aged; ROC Curve | 2017 |
Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Arginine; Biomarkers; Blood Pressure; Cholecalciferol; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Dietary Supplements; Elastic Tissue; Elasticity; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Male; Pulsatile Flow; Radioimmunoassay; Rats; Rats, Wistar; Streptozocin; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Vitamin D | 2012 |